oxaloacetic acid

N/A

Report date: 2022/08/29 20:00:24
NME

Base Information

Drug Nameoxaloacetic acid
Drug Alias Nameoxaloacetate2-Oxobutanedioic acidBenaGene
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsAmyotrophic Lateral SclerosisParkinson DiseaseMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTerra Biological Llc
China Registration ClassN/A

Develop Information

Active CompaniesTerra Biological Llc
Inactive CompaniesThe University Of Kansas Medical Center
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsParkinson DiseaseMyasthenia Gravis

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG